Assessment of the Effect of Sertaline on the Specific Binding of 123-I MZINT in Healthy Subjects
Status:
Terminated
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The overall purpose of this project is to evaluate the effect of sertraline administration on
the binding of 123-I mZINT in 10 healthy subjects. All study procedures will be conducted at
the Institute for Neurodegenerative Disorders (IND) and Molecular NeuroImaging (MNI) in New
Haven, CT.